GO:0002643 regulation of tolerance induction: Immune Tolerance Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002643 (regulation of tolerance induction) describes any process that modulates the frequency, rate, or extent of tolerance induction, the active establishment of unresponsiveness to a specific antigen.
• Tolerance induction is controlled at multiple levels, including dendritic cell instruction, regulatory T cell (Treg) activity, and transcriptional programs in responding T cells.
• NF-kB family transcription factors are central regulators that can either promote or restrain tolerance depending on subunit composition and context.
• The orphan nuclear receptor NR4A1 is a key mediator of T cell dysfunction and a transcriptional regulator of tolerance-associated gene programs.
• Microenvironmental and pharmacological cues, such as short-chain fatty acids, aspirin, TNF inhibitors, and high-dose immunoglobulins, can modulate tolerance induction.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of regulators of tolerance induction in immune cells.
Description
Regulation of tolerance induction (GO:0002643) is a biological process that encompasses any mechanism controlling the frequency, rate, or extent of tolerance induction, the active process by which the immune system becomes unresponsive to a given antigen. Tolerance induction is essential for preventing autoimmunity, limiting immunopathology, and permitting successful transplantation, and its dysregulation contributes to autoimmune disease, allergy, and tumor immune evasion. Because tolerance induction is not a passive default but an actively instructed state, it is subject to extensive regulation at the level of antigen-presenting cells, T cell transcription, and the tissue microenvironment. Understanding GO:0002643 therefore requires integrating dendritic cell biology, regulatory T cell (Treg) function, and the transcriptional and epigenetic circuits that enforce or break tolerance. This article summarizes the definition, mechanisms, key genes, disease links, and experimental methods used to study regulation of tolerance induction, with emphasis on CRISPR-based causal models.
regulation of tolerance induction At A Glance
| GO ID | GO:0002643 |
|---|---|
| GO term | regulation of tolerance induction |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate, or extent of tolerance induction, the active establishment of antigen-specific immune unresponsiveness |
| Key cell types | Dendritic cells, regulatory T cells, conventional T cells, and B cells |
| Key molecular regulators | NF-kB family transcription factors, NR4A1, and metabolic sensors such as mTOR-S6K |
| Disease relevance | Autoimmunity, transplantation tolerance, allergy, and tumor immune evasion |
| Research methods | CRISPR knockout/knock-in, flow cytometry, transcriptomics, and functional tolerance assays |
What Is GO:0002643?
GO:0002643, regulation of tolerance induction, is defined as any process that modulates the frequency, rate, or extent of tolerance induction. In practice, this means the collection of molecular and cellular events that set the threshold, duration, and specificity of the unresponsive state that the immune system establishes toward a particular antigen. Regulators can act on antigen-presenting cells to change how antigen is presented, on T cells to alter their differentiation or exhaustion programs, or on the tissue environment to provide tolerogenic or immunogenic cues.
Why Is regulation of tolerance induction Important in Cell Biology?
Regulation of tolerance induction is important because it determines whether the immune system responds to or ignores a given antigen, and small changes in this balance can cause autoimmunity, transplant rejection, or failure to control tumors. Because tolerance induction is actively regulated, it is also therapeutically tractable: dendritic cell manipulation, cytokine blockade, and metabolic modulation can all shift tolerance thresholds. Defining the regulators of GO:0002643 therefore has direct implications for understanding immune homeostasis and for designing antigen-specific immunotherapies.
• Controls the balance between protective immunity and autoimmunity.
• Underpins transplantation tolerance and rejection outcomes.
• Shapes allergy and antigen-specific desensitization responses.
• Influences tumor immune evasion and response to immunotherapy.
• Integrates metabolic and epigenetic signals into immune decisions.
• Provides targets for tolerogenic dendritic cell therapies.
• Is modulated by commonly used drugs such as aspirin and TNF inhibitors.
• Involves transcription factors such as NF-kB and NR4A1 that are druggable or genetically tractable.
• Can be studied with CRISPR screens to identify causal regulators.
• Has direct relevance to pemphigus and other autoantibody-mediated diseases.
What Happens During regulation of tolerance induction?
Antigen presentation and dendritic cell instruction
In simple terms: Dendritic cells decide whether to tell T cells to attack or to stand down.
Tolerance induction begins with antigen presentation by dendritic cells, which can be instructed to deliver tolerogenic rather than immunogenic signals. Manipulation of dendritic cells can promote tolerance in transplantation and autoimmune disease models, indicating that dendritic cell state is a regulated node in GO:0002643. Pharmacological agents such as aspirin can also influence the ability of dendritic cells to induce tolerance, showing that this step is responsive to external cues.
Regulatory T cell activity and suppression
In simple terms: Regulatory T cells act as brakes that enforce tolerance.
Regulatory T cells are central effectors of tolerance induction, and their activity is itself regulated by transcriptional and environmental inputs. High-dose immunoglobulins can induce T regulatory cell-associated tolerance in an HLA-transgenic mouse model of pemphigus, demonstrating that Treg-dependent tolerance induction is a modifiable process. Because Treg function is regulated, it represents a key node through which GO:0002643 can be tuned.
Transcriptional control by NF-kB family members
In simple terms: Transcription factors act as switches that turn tolerance programs on or off.
NF-kB family transcription factors are major regulators of immune tolerance, with different subunits promoting or restraining tolerance-associated gene expression. The contribution of NF-kB signalling to immune regulation and tolerance has been reviewed in detail, highlighting context-dependent outcomes. These transcription factors therefore act as regulated nodes within GO:0002643, integrating inflammatory and developmental signals.
NR4A1 and T cell dysfunction programs
In simple terms: NR4A1 helps push T cells into a dysfunctional, tolerance-like state.
Genome-wide analysis identified NR4A1 as a key mediator of T cell dysfunction, a state closely related to tolerance. NR4A1 acts as a transcriptional regulator that enforces programs of T cell unresponsiveness, and its activity is subject to regulation by upstream signals. This places NR4A1 within the regulatory network that controls tolerance induction.
Metabolic and epigenetic modulation
In simple terms: What cells eat and how their DNA is packaged can change tolerance.
Short-chain fatty acids induce both effector and regulatory T cells by suppressing histone deacetylases and regulating the mTOR-S6K pathway, showing that metabolic and epigenetic signals feed into tolerance regulation. These findings indicate that the frequency and extent of tolerance induction can be modulated by diet-derived metabolites and chromatin-modifying enzymes. Epigenetic regulation is therefore an integral part of GO:0002643.
Pharmacological and biologic modulation
In simple terms: Drugs and antibodies can shift the tolerance threshold.
TNF inhibitors can be immunogenic, and their immunogenicity illustrates how biologic therapies intersect with tolerance regulation. Aspirin has been studied for its effects on dendritic cell-mediated tolerance induction, providing an example of a small molecule that modulates GO:0002643. High-dose immunoglobulins can promote Treg-associated tolerance in a pemphigus model, further demonstrating pharmacological control of tolerance induction.
Key Genes Involved in GO:0002643 regulation of tolerance induction
The following genes and proteins have been experimentally implicated in the regulation of tolerance induction, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NFKB1 | NF-kB subunit that contributes to immune regulation and tolerance | Transcription factor node in tolerance induction |
| NFKB2 | NF-kB subunit with context-dependent roles in tolerance | Candidate for knockout studies of tolerance |
| REL | NF-kB family member regulating immune tolerance genes | Target for perturbation of tolerance programs |
| RELA | NF-kB subunit involved in immune regulation | Model for point-mutation studies |
| RELB | NF-kB subunit implicated in tolerance regulation | Knockout candidate for tolerance assays |
| NR4A1 | Key mediator of T cell dysfunction and tolerance-like programs | Central transcriptional regulator for CRISPR knockout |
| MTOR | Metabolic sensor regulating T cell fate via mTOR-S6K | Target for metabolic modulation of tolerance |
| RPS6KB1 | S6K kinase downstream of mTOR in T cell regulation | Node for metabolic-epigenetic crosstalk |
| HDAC1 | Histone deacetylase targeted by short-chain fatty acids | Epigenetic regulator of tolerance induction |
| HDAC2 | Histone deacetylase implicated in SCFA-mediated T cell regulation | Candidate for epigenetic editing |
| HDAC3 | Histone deacetylase contributing to T cell regulation | Target for knockout in tolerance models |
| FOXP3 | Master transcription factor of regulatory T cells | Central to Treg-dependent tolerance |
| TNF | Cytokine whose inhibition can affect immunogenicity and tolerance | Relevant to biologic-induced tolerance changes |
| HLA-DRB1 | Antigen-presentation molecule in HLA-transgenic pemphigus model | Model for antigen-specific tolerance studies |
| PTGS1 | Target of aspirin in dendritic cell tolerance studies | Pharmacological node for tolerance modulation |
| PTGS2 | Aspirin target implicated in dendritic cell tolerance | Candidate for small-molecule studies |
How Is regulation of tolerance induction Regulated?
Regulation of tolerance induction is itself regulated by multiple inputs. The mTOR-S6K pathway integrates metabolic signals and is suppressed by short-chain fatty acids, which also inhibit histone deacetylases, thereby influencing both effector and regulatory T cell differentiation. NF-kB family transcription factors provide transcriptional control that can either promote or restrain tolerance depending on subunit composition and cellular context. NR4A1 acts as a key transcriptional mediator of T cell dysfunction, a state that overlaps with tolerance. Pharmacological agents such as aspirin, TNF inhibitors, and high-dose immunoglobulins can further modulate tolerance induction at the level of dendritic cells and Tregs.
regulation of tolerance induction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NR4A1 | T cell dysfunction and tumor immune evasion | Knockout and overexpression in T cells |
| FOXP3 | Autoimmunity and Treg deficiency | Knock-in reporter for Treg tracking |
| HLA-DRB1 | Pemphigus in HLA-transgenic model | HLA-transgenic mouse for tolerance induction |
| TNF | Immunogenicity of TNF inhibitors | Point-mutation and knockout models |
| NFKB1 | Immune dysregulation and tolerance defects | Conditional knockout in immune cells |
Autoimmune disease and pemphigus
Failure to regulate tolerance induction can lead to autoantibody-mediated diseases such as pemphigus, where high-dose immunoglobulins can restore T regulatory cell-associated tolerance in an HLA-transgenic mouse model. Autoimmune disease more broadly reflects an imbalance in the regulatory circuits that control tolerance induction.
Transplantation tolerance and rejection
Manipulation of dendritic cells to induce tolerance has been explored in transplantation, where the goal is to prevent rejection without lifelong immunosuppression. The regulation of tolerance induction is therefore a central determinant of transplant outcomes.
Cancer immune evasion
T cell dysfunction programs mediated by NR4A1 contribute to tumor immune evasion, and NR4A1 is a key mediator of this dysfunctional state. Because these programs overlap with tolerance induction, regulators of GO:0002643 are relevant to cancer immunotherapy resistance.
Drug-induced immunogenicity
TNF inhibitors can be immunogenic, and this immunogenicity reflects altered regulation of tolerance induction against the biologic agent. Understanding these mechanisms is important for predicting and managing loss of drug response.
From regulation of tolerance induction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for tolerance induction? | CRISPR knockout in primary T cells or dendritic cells |
| Does a specific amino acid change alter tolerance regulation? | CRISPR point mutation knock-in |
| Can a tolerogenic gene program be tracked in vivo? | Tagged knock-in reporter |
| Does overexpression of a regulator break tolerance? | CRISPR overexpression model |
| Which metabolic pathways modulate tolerance? | Knockout of mTOR-S6K components |
| Can pharmacological agents restore tolerance? | HLA-transgenic pemphigus model with high-dose immunoglobulin |
How to Study the regulation of tolerance induction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Treg frequency and phenotype | Assessing tolerance induction in vivo |
| In vitro suppression assay | Treg suppressive function | Testing whether regulators control tolerance |
| RNA-seq | Transcriptional programs of tolerance | Identifying NF-kB and NR4A1 target genes |
| ATAC-seq | Chromatin accessibility changes | Mapping epigenetic regulation of tolerance |
| Metabolic assays | mTOR-S6K activity | Testing SCFA effects on T cells |
| Pharmacological profiling | Drug effects on dendritic cells | Screening tolerance-modulating compounds |
| HLA-transgenic mouse model | Treg-associated tolerance in pemphigus | Testing high-dose immunoglobulin therapy |
Flow cytometry and suppression assays
Flow cytometry can quantify Treg frequencies and activation states, while in vitro suppression assays measure the functional capacity of Tregs to enforce tolerance. These methods are used to assess whether genetic perturbations alter tolerance induction.
Transcriptomics and epigenomics
RNA-seq and chromatin accessibility assays can identify transcriptional and epigenetic changes associated with tolerance induction, including NF-kB-dependent and NR4A1-dependent programs. Genome-wide analysis has been used to identify NR4A1 as a key mediator of T cell dysfunction.
Metabolic and pharmacological profiling
Metabolic assays can measure mTOR-S6K activity and the effects of short-chain fatty acids on T cell differentiation. Pharmacological profiling with aspirin or TNF inhibitors can reveal how drugs modulate tolerance induction.
In vivo tolerance models
HLA-transgenic mouse models of pemphigus allow testing of high-dose immunoglobulins and other agents for their ability to induce Treg-associated tolerance. Transplantation models can assess dendritic cell-mediated tolerance induction.
How CRISPR Can Be Used to Study GO:0002643 regulation of tolerance induction
Knockout
CRISPR knockout of candidate regulators such as NR4A1 or NF-kB subunits can test whether they are required for tolerance induction in primary T cells or dendritic cells. Loss-of-function models help establish causality for GO:0002643.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes in transcription factors or signaling proteins to dissect domain-specific functions in tolerance regulation. This approach is useful when complete knockout is lethal or confounded by redundancy.
Knock-in
Knock-in of reporters or tags allows tracking of tolerance-associated gene expression and protein localization in vivo. Tagged knock-in models can also facilitate chromatin immunoprecipitation studies of NF-kB or NR4A1.
Overexpression
CRISPR overexpression can test whether increasing the level of a regulator is sufficient to break or enforce tolerance. This is particularly informative for metabolic regulators such as mTOR pathway components.
How EDITGENE Supports regulation of tolerance induction Research
Researchers studying regulation of tolerance induction-related genes often need to determine whether a candidate gene is causally involved in setting the threshold for immune unresponsiveness. EDITGENE provides end-to-end CRISPR services to generate precisely engineered immune cell models for such causal studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of tolerance induction research.
Frequently Asked Questions About regulation of tolerance induction
What is GO:0002643 regulation of tolerance induction?
GO:0002643 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate, or extent of tolerance induction, the active establishment of antigen-specific immune unresponsiveness.
What genes are involved in regulation of tolerance induction?
Key genes include NF-kB family members such as NFKB1 and RELA, the nuclear receptor NR4A1, FOXP3, and metabolic regulators such as MTOR and RPS6KB1.
How is tolerance induction regulated at the molecular level?
Tolerance induction is regulated by transcription factors such as NF-kB and NR4A1, by metabolic sensors such as mTOR-S6K, and by epigenetic modifiers such as histone deacetylases.
What role do dendritic cells play in tolerance induction?
Dendritic cells can be manipulated to induce tolerance in transplantation and autoimmune disease, making them a key regulated node in GO:0002643.
How do short-chain fatty acids affect tolerance induction?
Short-chain fatty acids induce both effector and regulatory T cells by suppressing histone deacetylases and regulating the mTOR-S6K pathway, thereby modulating tolerance.
What is the role of NR4A1 in tolerance?
NR4A1 was identified as a key mediator of T cell dysfunction, a state closely related to tolerance induction.
Can drugs modulate regulation of tolerance induction?
Yes, aspirin has been studied for its effects on dendritic cell-mediated tolerance, and high-dose immunoglobulins can induce Treg-associated tolerance in a pemphigus model.
How do TNF inhibitors relate to tolerance induction?
TNF inhibitors can be immunogenic, and their immunogenicity reflects altered regulation of tolerance induction against the biologic agent.
What diseases are linked to defective regulation of tolerance induction?
Defective tolerance regulation is linked to autoimmune diseases such as pemphigus, transplant rejection, and cancer immune evasion.
How can CRISPR be used to study regulation of tolerance induction?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate regulators in immune cells.
Conclusion
GO:0002643, regulation of tolerance induction, captures the active and multi-layered control of immune unresponsiveness. Its key regulators include NF-kB transcription factors, NR4A1, FOXP3, and metabolic-epigenetic pathways such as mTOR-S6K and histone deacetylases. Dysregulation of these circuits contributes to autoimmunity, transplant rejection, and tumor immune evasion, making them attractive therapeutic targets. CRISPR-based models provide a rigorous path to establish causality and to discover new regulators of tolerance induction.
References
- 1. Park J et al.. 2015. Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway.. Mucosal Immunol 8(1):80-93 PMID: 24917457
- 2. Zhang L et al.. 2019. Transcriptional and epigenetic regulation of immune tolerance: roles of the NF-κB family members.. Cell Mol Immunol 16(4):315-323 PMID: 30872809
- 3. Liu X et al.. 2019. Genome-wide analysis identifies NR4A1 as a key mediator of T cell dysfunction.. Nature 567(7749):525-529 PMID: 30814730
- 4. van Delft MA et al.. 2015. The contribution of NF-κB signalling to immune regulation and tolerance.. Eur J Clin Invest 45(5):529-39 PMID: 25735405
- 5. Buckland M et al.. 2009. Aspirin and the induction of tolerance by dendritic cells.. Handb Exp Pharmacol PMID: 19031027
- 6. Atiqi S et al.. 2020. Immunogenicity of TNF-Inhibitors.. Front Immunol 11:312 PMID: 32174918
- 7. Lu L et al.. 2002. Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease.. Transplantation 73(1 Suppl):S19-22 PMID: 11810056
- 8. Hudemann C et al.. 2023. T Regulatory Cell-Associated Tolerance Induction by High-Dose Immunoglobulins in an HLA-Transgenic Mouse Model of Pemphigus.. Cells 12(9) PMID: 37174740
